![]()
Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | Slc37a1 | Mouse | (1->4)-beta-D-glucan | multiple interactions | EXP | | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of SLC37A1 mRNA | CTD | PMID:36331819 | Slc37a1 | Mouse | 1,2-dimethylhydrazine | multiple interactions | EXP | | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of SLC37A1 mRNA | CTD | PMID:22206623 | Slc37a1 | Mouse | 17beta-estradiol | decreases expression | EXP | | 6480464 | Estradiol results in decreased expression of SLC37A1 mRNA | CTD | PMID:28476547 | Slc37a1 | Mouse | 2,2',4,4'-Tetrabromodiphenyl ether | increases expression | ISO | Slc37a1 (Rattus norvegicus) | 6480464 | 2 more ... | CTD | PMID:27291303 | Slc37a1 | Mouse | 2,2',4,4'-Tetrabromodiphenyl ether | affects expression | EXP | | 6480464 | 2 more ... | CTD | PMID:30294300 | Slc37a1 | Mouse | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | Slc37a1 (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of SLC37A1 mRNA | CTD | PMID:33387578 | Slc37a1 | Mouse | 2,4-dibromophenyl 2,4,5-tribromophenyl ether | increases expression | ISO | SLC37A1 (Homo sapiens) | 6480464 | 2 more ... | CTD | PMID:26705709 | Slc37a1 | Mouse | 3-iodothyronamine | affects uptake | ISO | SLC37A1 (Homo sapiens) | 6480464 | SLC37A1 mRNA affects the uptake of 3-iodothyronamine | CTD | PMID:19074582 | Slc37a1 | Mouse | 3-Nitrobenzanthrone | decreases expression | ISO | SLC37A1 (Homo sapiens) | 6480464 | 3-nitrobenzanthrone results in decreased expression of SLC37A1 mRNA | CTD | PMID:34036453 | Slc37a1 | Mouse | 4,4'-sulfonyldiphenol | affects expression | EXP | | 6480464 | bisphenol S affects the expression of SLC37A1 mRNA | CTD | PMID:39298647 | Slc37a1 | Mouse | all-trans-retinoic acid | increases expression | ISO | SLC37A1 (Homo sapiens) | 6480464 | Tretinoin results in increased expression of SLC37A1 mRNA | CTD | PMID:33167477 | Slc37a1 | Mouse | antirheumatic drug | decreases expression | ISO | SLC37A1 (Homo sapiens) | 6480464 | Antirheumatic Agents results in decreased expression of SLC37A1 mRNA | CTD | PMID:24449571 | Slc37a1 | Mouse | aristolochic acid A | increases expression | ISO | SLC37A1 (Homo sapiens) | 6480464 | aristolochic acid I results in increased expression of SLC37A1 mRNA | CTD | PMID:33212167 | Slc37a1 | Mouse | benzo[a]pyrene | increases methylation | ISO | SLC37A1 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased methylation of SLC37A1 exon | CTD | PMID:27901495 | Slc37a1 | Mouse | benzo[a]pyrene | decreases methylation | ISO | SLC37A1 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in decreased methylation of SLC37A1 5' UTR | CTD | PMID:27901495 | Slc37a1 | Mouse | benzo[e]pyrene | increases methylation | ISO | SLC37A1 (Homo sapiens) | 6480464 | benzo(e)pyrene results in increased methylation of SLC37A1 intron | CTD | PMID:30157460 | Slc37a1 | Mouse | bis(2-ethylhexyl) phthalate | decreases expression | EXP | | 6480464 | Diethylhexyl Phthalate results in decreased expression of SLC37A1 mRNA | CTD | PMID:35550907 | Slc37a1 | Mouse | bis(2-ethylhexyl) phthalate | increases expression | EXP | | 6480464 | Diethylhexyl Phthalate results in increased expression of SLC37A1 mRNA | CTD | PMID:34319233 | Slc37a1 | Mouse | bisphenol A | increases expression | ISO | Slc37a1 (Rattus norvegicus) | 6480464 | bisphenol A results in increased expression of SLC37A1 mRNA | CTD | PMID:25181051 | Slc37a1 | Mouse | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of SLC37A1 mRNA and bisphenol A results in decreased expression of SLC37A1 protein | CTD | PMID:28476547 | Slc37a1 | Mouse | bisphenol A | decreases expression | ISO | Slc37a1 (Rattus norvegicus) | 6480464 | bisphenol A results in decreased expression of SLC37A1 mRNA | CTD | PMID:30816183 more ... | Slc37a1 | Mouse | C60 fullerene | increases expression | ISO | Slc37a1 (Rattus norvegicus) | 6480464 | fullerene C60 results in increased expression of SLC37A1 mRNA | CTD | PMID:19167457 | Slc37a1 | Mouse | cadmium dichloride | decreases expression | EXP | | 6480464 | Cadmium Chloride results in decreased expression of SLC37A1 mRNA | CTD | PMID:24982889 | Slc37a1 | Mouse | cadmium dichloride | increases expression | ISO | SLC37A1 (Homo sapiens) | 6480464 | Cadmium Chloride results in increased expression of SLC37A1 mRNA | CTD | PMID:38568856 | Slc37a1 | Mouse | calyculin a | decreases expression | EXP | | 6480464 | calyculin A results in decreased expression of SLC37A1 mRNA | CTD | PMID:25270620 | Slc37a1 | Mouse | capsaicin | decreases expression | ISO | Slc37a1 (Rattus norvegicus) | 6480464 | Capsaicin results in decreased expression of SLC37A1 mRNA | CTD | PMID:20349343 | Slc37a1 | Mouse | carbon nanotube | increases expression | EXP | | 6480464 | Nanotubes more ... | CTD | PMID:25620056 | Slc37a1 | Mouse | CGP 52608 | multiple interactions | ISO | SLC37A1 (Homo sapiens) | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to SLC37A1 gene] | CTD | PMID:28238834 | Slc37a1 | Mouse | cisplatin | increases expression | ISO | SLC37A1 (Homo sapiens) | 6480464 | Cisplatin results in increased expression of SLC37A1 mRNA | CTD | PMID:27392435 | Slc37a1 | Mouse | cisplatin | multiple interactions | ISO | SLC37A1 (Homo sapiens) | 6480464 | [Cisplatin co-treated with jinfukang] results in increased expression of SLC37A1 mRNA | CTD | PMID:27392435 | Slc37a1 | Mouse | diclofenac | increases expression | EXP | | 6480464 | Diclofenac results in increased expression of SLC37A1 mRNA | CTD | PMID:26934552 | Slc37a1 | Mouse | folic acid | multiple interactions | EXP | | 6480464 | [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of SLC37A1 mRNA | CTD | PMID:22206623 | Slc37a1 | Mouse | genistein | decreases expression | EXP | | 6480464 | Genistein results in decreased expression of SLC37A1 mRNA | CTD | PMID:32186404 | Slc37a1 | Mouse | gentamycin | decreases expression | ISO | Slc37a1 (Rattus norvegicus) | 6480464 | Gentamicins results in decreased expression of SLC37A1 mRNA | CTD | PMID:33387578 | Slc37a1 | Mouse | manganese atom | multiple interactions | ISO | SLC37A1 (Homo sapiens) | 6480464 | [manganese chloride results in increased abundance of Manganese] which results in increased expression of SLC37A1 mRNA | CTD | PMID:39836092 | Slc37a1 | Mouse | manganese(0) | multiple interactions | ISO | SLC37A1 (Homo sapiens) | 6480464 | [manganese chloride results in increased abundance of Manganese] which results in increased expression of SLC37A1 mRNA | CTD | PMID:39836092 | Slc37a1 | Mouse | manganese(II) chloride | multiple interactions | ISO | SLC37A1 (Homo sapiens) | 6480464 | [manganese chloride results in increased abundance of Manganese] which results in increased expression of SLC37A1 mRNA | CTD | PMID:39836092 | Slc37a1 | Mouse | methapyrilene | increases methylation | ISO | SLC37A1 (Homo sapiens) | 6480464 | Methapyrilene results in increased methylation of SLC37A1 intron | CTD | PMID:30157460 | Slc37a1 | Mouse | methotrexate | affects expression | EXP | | 6480464 | Methotrexate affects the expression of SLC37A1 mRNA | CTD | PMID:18502557 | Slc37a1 | Mouse | nickel sulfate | increases expression | ISO | SLC37A1 (Homo sapiens) | 6480464 | nickel sulfate results in increased expression of SLC37A1 mRNA | CTD | PMID:22714537 | Slc37a1 | Mouse | paracetamol | affects expression | EXP | | 6480464 | Acetaminophen affects the expression of SLC37A1 mRNA | CTD | PMID:17562736 | Slc37a1 | Mouse | paracetamol | increases expression | ISO | Slc37a1 (Rattus norvegicus) | 6480464 | Acetaminophen results in increased expression of SLC37A1 mRNA | CTD | PMID:33387578 | Slc37a1 | Mouse | perfluorohexanesulfonic acid | decreases expression | ISO | SLC37A1 (Homo sapiens) | 6480464 | perfluorohexanesulfonic acid results in decreased expression of SLC37A1 mRNA | CTD | PMID:25812627 | Slc37a1 | Mouse | perfluorononanoic acid | decreases expression | ISO | SLC37A1 (Homo sapiens) | 6480464 | perfluoro-n-nonanoic acid results in decreased expression of SLC37A1 mRNA | CTD | PMID:25812627 | Slc37a1 | Mouse | perfluorooctane-1-sulfonic acid | multiple interactions | EXP | | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of SLC37A1 mRNA | CTD | PMID:36331819 | Slc37a1 | Mouse | perfluorooctane-1-sulfonic acid | decreases expression | ISO | SLC37A1 (Homo sapiens) | 6480464 | perfluorooctane sulfonic acid results in decreased expression of SLC37A1 mRNA | CTD | PMID:25812627 | Slc37a1 | Mouse | perfluorooctanoic acid | decreases expression | ISO | SLC37A1 (Homo sapiens) | 6480464 | perfluorooctanoic acid results in decreased expression of SLC37A1 mRNA | CTD | PMID:25812627 | Slc37a1 | Mouse | phenobarbital | multiple interactions | EXP | | 6480464 | NR1I3 protein affects the reaction [Phenobarbital results in increased expression of SLC37A1 mRNA] | CTD | PMID:19482888 | Slc37a1 | Mouse | phenobarbital | increases expression | EXP | | 6480464 | Phenobarbital results in increased expression of SLC37A1 mRNA | CTD | PMID:19482888 and PMID:23091169 | Slc37a1 | Mouse | tamoxifen | decreases expression | EXP | | 6480464 | Tamoxifen results in decreased expression of SLC37A1 mRNA | CTD | PMID:25123088 | Slc37a1 | Mouse | thioacetamide | increases expression | ISO | Slc37a1 (Rattus norvegicus) | 6480464 | Thioacetamide results in increased expression of SLC37A1 mRNA | CTD | PMID:34492290 | Slc37a1 | Mouse | titanium dioxide | decreases methylation | EXP | | 6480464 | titanium dioxide results in decreased methylation of SLC37A1 gene | CTD | PMID:35295148 | Slc37a1 | Mouse | tributylstannane | increases expression | EXP | | 6480464 | tributyltin results in increased expression of SLC37A1 mRNA | CTD | PMID:31939706 | Slc37a1 | Mouse | trichloroethene | increases expression | EXP | | 6480464 | Trichloroethylene results in increased expression of SLC37A1 mRNA | CTD | PMID:25549359 | Slc37a1 | Mouse | triphenyl phosphate | affects expression | ISO | SLC37A1 (Homo sapiens) | 6480464 | triphenyl phosphate affects the expression of SLC37A1 mRNA | CTD | PMID:37042841 | Slc37a1 | Mouse | valproic acid | increases expression | ISO | SLC37A1 (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of SLC37A1 mRNA | CTD | PMID:24383497 | Slc37a1 | Mouse | valproic acid | decreases expression | ISO | SLC37A1 (Homo sapiens) | 6480464 | Valproic Acid results in decreased expression of SLC37A1 mRNA | CTD | PMID:29154799 | Slc37a1 | Mouse | vinclozolin | decreases expression | ISO | Slc37a1 (Rattus norvegicus) | 6480464 | vinclozolin results in decreased expression of SLC37A1 mRNA | CTD | PMID:23034163 | Slc37a1 | Mouse | zidovudine | increases expression | ISO | SLC37A1 (Homo sapiens) | 6480464 | Zidovudine results in increased expression of SLC37A1 mRNA | CTD | PMID:24292225 | Slc37a1 | Mouse | zoledronic acid | increases expression | ISO | SLC37A1 (Homo sapiens) | 6480464 | zoledronic acid results in increased expression of SLC37A1 mRNA | CTD | PMID:24714768 | |